Goldman Sachs Group »

Conduit Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $21k 20k 1.06
2024-03-31 $252k 69k 3.67

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Conduit Pharmaceuticals

Barclays
BlackRock
BlackRock
Geode Capital Management
Vanguard Group
Citadel Advisors
Northern Trust
New York State Common Retirement Fund
State Street Corporation
Morgan Stanley
Charles Schwab Investment Management
Bridgeway Capital Management
JustInvest
SG Americas Securities
AQR Capital Management

View all funds holding Conduit Pharmaceuticals